Clinical Outcomes Of Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Receiving Radium-223 (Ra-223) Early Versus Late In The Treatment Sequence.

JOURNAL OF CLINICAL ONCOLOGY(2021)

引用 2|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要